OpenLegislation

The Misuse of Drugs (Amendment No.3) Regulations (Northern Ireland) 2014

S.R. 2014/261 · Made 21 October 2014

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Dangerous Drugs

Made 21st October 2014

Coming into operation 11th November 2014

The Department of Health, Social Services and Public Safety, makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971 f1 as adapted by sections 7(9), 31(4) and 38 of that Act and now vested in it f2 and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 31(3) of that Act.

Annotations to the whole text

Footnotes

f1

1971 c.38. as amended by s.151 of, and Schedule 17 to, the Police Reform and Social Responsibility Act 2011 c.13.

f2

S.R. & O. (N.I.) 1973 No.504, Article 5(a) and S.I.1999/283 (N.I.1), Article 3(6).

Contents

  1. 1Citation, commencement and interpretation
  2. 2Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
  3. 3Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
  4. Signature
  5. Explanatory note

1Citation, commencement and interpretation

(1)

These Regulations may be cited as the Misuse of Drugs (Amendment No. 3) Regulations (Northern Ireland) 2014 and shall come into operation on 11th November 2014.

(2)

The Interpretation Act (Northern Ireland) 1954 f1 shall apply to these Regulations as it applies to an Act of the Northern Ireland Assembly.

2Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

The Misuse of Drugs Regulations (Northern Ireland) 2002 f1 shall be amended as provided by regulation 3.

3Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) after “9-(Hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7, 10, 10a-tetrahydrobenzo[c]chromen-1-ol” insert—

“Khat”

Signature

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 21st October 2014

L.S.

Dr. Anne Kilgallen

A senior officer of the

Department of Health, Social Services and Public Safety

Explanatory note

(This note is not part of the Regulation)

These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 in order to add Khat to Schedule 1 of those Regulations. The Schedule in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug.